Evaluation of the Therapeutic Efficacy of Levocarnitine and L-Arginine Hydrochloride in Patients with Unstable Angina at a Young Age

In this scientific work, we studied the effect of Levargin on some clinical and laboratory parameters and the course of unstable variants of angina pectoris in men at a young age. The study included 72 male patients aged 21 to 44 years who were hospitalized in emergency departments No. 2 in the period from 2022 to 2023 on the basis of the Samarkand branch of the Republican Scientific and Practical Center for Emergency Medical Care (SF RNPCEMP). All patients underwent a general clinical examination (anamnesis collection, anthropometric and physical examination of the patient, measurement of blood pressure, heart rate). Laboratory and instrumental examination included clinical blood tests, biochemical blood analysis, examination of hemostasis parameters, cytokines (interleukin 1-beta (IL-1β), IL-6, tumor necrosis factor-alpha (TNF-α) upon admission and in dynamics on the 2nd and 7th day of admission, ECG, echocardiography, lung radiography, ultrasound according to indications. Studies have shown the positive clinical efficacy of Levargin and allows it to be recommended in the treatment of patients with unstable angina pectoris as part of basic therapy.